Efficacy of controlled-release dinoprostone vaginal insert for elective induction of labor before due date

缓释地诺前列酮阴道栓剂用于择期引产的疗效

阅读:1

Abstract

AIM: The induction of labor before due date has recently been proved to reduce the rate of cesarean sections and is not associated with increased risk of adverse perinatal outcomes as compared to expectant management. Controlled-release dinoprostone (PGE(2)) vaginal insert has recently been approved for use in Japan. However, evidence regarding its efficacy in cervical ripening and labor induction before due date remains limited. We aimed to compare the efficacy of PGE(2) vaginal inserts and mechanical dilation for labor induction before due date. METHODS: This retrospective cohort study included 206 mothers at 37, 38, and 39 weeks' gestation delivered at our institution between January 2021 and October 2022. Perinatal outcomes, including the success rate of vaginal delivery, were compared between the PGE(2) (n = 46) and metreurynter/laminaria tent (non-PGE(2)) (n = 160) groups. The success rate of vaginal delivery was defined as the proportion of women who delivered vaginally within 48 h of initiating oxytocin augmentation. RESULTS: The success rate of vaginal delivery was significantly higher in the PGE(2) group (37/49, 80.4%) than in the non-PGE(2) group (106/177, 66.2%). Emergency cesarean section related to non-reassuring fetal status was performed with none in the PGE(2) group and with eight (5.0%) in the non-PGE(2) group. CONCLUSIONS: The rate of vaginal delivery was significantly higher in the PGE(2) group for elective labor induction between 37 and 39 weeks. The PGE(2) vaginal insert could increase the success rate of vaginal delivery for elective induction of labor at 39 weeks.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。